Arpna Srivastava

705 total citations
26 papers, 510 citations indexed

About

Arpna Srivastava is a scholar working on Molecular Biology, Genetics and Psychiatry and Mental health. According to data from OpenAlex, Arpna Srivastava has authored 26 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Genetics and 7 papers in Psychiatry and Mental health. Recurrent topics in Arpna Srivastava's work include Epilepsy research and treatment (7 papers), Genetics and Neurodevelopmental Disorders (7 papers) and Neuroscience and Neuropharmacology Research (5 papers). Arpna Srivastava is often cited by papers focused on Epilepsy research and treatment (7 papers), Genetics and Neurodevelopmental Disorders (7 papers) and Neuroscience and Neuropharmacology Research (5 papers). Arpna Srivastava collaborates with scholars based in India and United Kingdom. Arpna Srivastava's co-authors include Jasbir Kaur, Manjari Tripathi, Jyotirmoy Banerjee, P. Sarat Chandra, Aparna Banerjee Dixit, Ramanjit Sihota, Amita Goyal, Chitra Sarkar, Aanchal Kakkar and Medha Rajappa and has published in prestigious journals such as Cancer Research, Scientific Reports and Neuroscience.

In The Last Decade

Arpna Srivastava

25 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arpna Srivastava India 12 261 134 107 83 73 26 510
Moulinath Acharya India 14 387 1.5× 398 3.0× 95 0.9× 52 0.6× 88 1.2× 37 773
Rosemary Burgess Australia 13 521 2.0× 144 1.1× 195 1.8× 159 1.9× 224 3.1× 19 808
Richard B. Crook United States 16 398 1.5× 97 0.7× 173 1.6× 9 0.1× 28 0.4× 28 599
A L United States 9 461 1.8× 271 2.0× 217 2.0× 18 0.2× 20 0.3× 11 862
Annett Spudich Switzerland 6 258 1.0× 68 0.5× 61 0.6× 17 0.2× 8 0.1× 7 524
Kevin M. Kaltenbronn United States 13 632 2.4× 61 0.5× 115 1.1× 9 0.1× 44 0.6× 19 840
A M Bogardus United States 7 255 1.0× 117 0.9× 119 1.1× 11 0.1× 134 1.8× 8 682
Ulrike Harms Germany 11 263 1.0× 19 0.1× 100 0.9× 14 0.2× 19 0.3× 12 527
Karen Duong‐Polk United States 12 384 1.5× 295 2.2× 74 0.7× 10 0.1× 11 0.2× 16 603
Shanu Markand United States 13 342 1.3× 117 0.9× 68 0.6× 17 0.2× 10 0.1× 21 535

Countries citing papers authored by Arpna Srivastava

Since Specialization
Citations

This map shows the geographic impact of Arpna Srivastava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arpna Srivastava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arpna Srivastava more than expected).

Fields of papers citing papers by Arpna Srivastava

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arpna Srivastava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arpna Srivastava. The network helps show where Arpna Srivastava may publish in the future.

Co-authorship network of co-authors of Arpna Srivastava

This figure shows the co-authorship network connecting the top 25 collaborators of Arpna Srivastava. A scholar is included among the top collaborators of Arpna Srivastava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arpna Srivastava. Arpna Srivastava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Srivastava, Arpna, Parasmani Rajput, P. Sarat Chandra, et al.. (2024). Integrated Proteomics and Protein Co-expression Network Analysis Identifies Novel Epileptogenic Mechanism in Mesial Temporal Lobe Epilepsy. Molecular Neurobiology. 61(11). 9663–9679. 1 indexed citations
4.
Dixit, Aparna Banerjee, Arpna Srivastava, Jyotirmoy Banerjee, et al.. (2022). Altered expression of activating transcription factor 3 in the hippocampus of patients with mesial temporal lobe epilepsy-hippocampal sclerosis (MTLE-HS). International Journal of Neuroscience. 134(3). 267–273. 3 indexed citations
5.
6.
Srivastava, Arpna, Krishan Kumar, Jyotirmoy Banerjee, et al.. (2021). Transcriptomic profiling of high- and low-spiking regions reveals novel epileptogenic mechanisms in focal cortical dysplasia type II patients. Molecular Brain. 14(1). 120–120. 11 indexed citations
7.
8.
Attrish, Diksha, Arpna Srivastava, Jyotirmoy Banerjee, et al.. (2020). Non-histone substrates of histone deacetylases as potential therapeutic targets in epilepsy. Expert Opinion on Therapeutic Targets. 25(1). 75–85. 23 indexed citations
9.
Srivastava, Arpna, Jyotirmoy Banerjee, Manjari Tripathi, et al.. (2020). Role of Altered Expression, Activity and Sub-cellular Distribution of Various Histone Deacetylases (HDACs) in Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis. Cellular and Molecular Neurobiology. 42(4). 1049–1064. 24 indexed citations
10.
Dixit, Aparna Banerjee, Arpna Srivastava, Manjari Tripathi, et al.. (2018). Altered transforming growth factor beta/SMAD3 signalling in patients with hippocampal sclerosis. Epilepsy Research. 146. 144–150. 13 indexed citations
11.
Dixit, Aparna Banerjee, Manjari Tripathi, Arpna Srivastava, et al.. (2018). Genome-wide DNA Methylation and RNAseq Analyses Identify Aberrant Signalling Pathways in Focal Cortical Dysplasia (FCD) Type II. Scientific Reports. 8(1). 17976–17976. 29 indexed citations
12.
Srivastava, Arpna, et al.. (2018). Expression Profile of Histone Deacetylases in Patients with Hippocampal Sclerosis. 1 indexed citations
13.
Dixit, Aparna Banerjee, et al.. (2017). Upregulation of breast cancer resistance protein and major vault protein in drug resistant epilepsy. Seizure. 47. 9–12. 26 indexed citations
14.
Srivastava, Arpna, Sunil Kumar, Sandeep Goswami, et al.. (2017). Expression of multidrug resistance proteins in retinoblastoma. International Journal of Ophthalmology. 10(11). 1655–1661. 18 indexed citations
15.
Banerjee, Jyotirmoy, Arpna Srivastava, Bhargavi Ramanujam, et al.. (2017). Altered glutamatergic tone reveals two distinct resting state networks at the cellular level in hippocampal sclerosis. Scientific Reports. 7(1). 319–319. 23 indexed citations
16.
Dixit, Aparna Banerjee, Jyotirmoy Banerjee, Arpna Srivastava, et al.. (2016). RNA-seq analysis of hippocampal tissues reveals novel candidate genes for drug refractory epilepsy in patients with MTLE-HS. Genomics. 107(5). 178–188. 66 indexed citations
17.
18.
Srivastava, Arpna, Aparna Banerjee Dixit, Jyotirmoy Banerjee, Manjari Tripathi, & P. Sarat Chandra. (2015). Role of inflammation and its miRNA based regulation in epilepsy: Implications for therapy. Clinica Chimica Acta. 452. 1–9. 40 indexed citations
19.
Goswami, Sandeep, Viney Gupta, Arpna Srivastava, et al.. (2014). A novel duplication in the PAX6 gene in a North Indian family with aniridia. International Ophthalmology. 34(6). 1183–1188. 2 indexed citations
20.
Srivastava, Arpna, Medha Rajappa, & Jasbir Kaur. (2010). Uveitis: Mechanisms and recent advances in therapy. Clinica Chimica Acta. 411(17-18). 1165–1171. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Moulinath Acharya Breakdown of academic impact, for papers by Rosemary Burgess Breakdown of academic impact, for papers by Richard B. Crook Breakdown of academic impact, for papers by A L Breakdown of academic impact, for papers by Annett Spudich Breakdown of academic impact, for papers by Kevin M. Kaltenbronn Breakdown of academic impact, for papers by A M Bogardus Breakdown of academic impact, for papers by Ulrike Harms Breakdown of academic impact, for papers by Karen Duong‐Polk Breakdown of academic impact, for papers by Shanu Markand
Rankless by CCL
2026